Therapeutics

400+ Companies
More info
Parent markets
Sibling markets
Related markets
400+ companies in Therapeutics
Show all
Amgen Inc.

Amgen Inc.

Manufacturing +2
Seattle Genetics

Seattle Genetics

Health Care +2
Takeda

Takeda

Pharmaceuticals +1
Aimmune

Aimmune

Health and Wellness +2
Kaia Health

Kaia Health

Artificial Intelligence +2
Cerevel Therapeutics

Cerevel Therapeutics

Biotechnology +1
Moderna Therapeutics

Moderna Therapeutics

Biotechnology +1
Xealth

Xealth

Personal Health +3
Joint Academy

Joint Academy

Cloud Computing +6
Immusoft

Immusoft

Biotechnology +1
Beam Therapeutics

Beam Therapeutics

Health Care +1
Aspen Neuroscience

Aspen Neuroscience

Medical +2
Relay Therapeutics

Relay Therapeutics

Health Care +2
Cyteir

Cyteir

Biotechnology +1
Nohla Therapeutics

Nohla Therapeutics

Biotechnology +2
All companies in Therapeutics
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Filter companies
25 Aug 2020
CerSci Therapeutics
CerSci Therapeutics
$52,500,000 From
ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc.

Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout

Xconomy
11 Aug 2020
KaNDy Therapeutics
KaNDy Therapeutics
$450,000,000 From
Bayer
Bayer

Bayer to Buy KaNDy Therapeutics

FinSMEs
23 Jul 2020
Dana Solutions
Dana Solutions
Acquired by
Curi Bio
Curi Bio
20 Jul 2020
Syracuse Biopharma
Syracuse Biopharma
Acquired by
JW Therapeutics
JW Therapeutics

JW Therapeutics Acquires Syracuse Biopharma

FinSMEs
19 May 2020
Physera
Physera
Acquired by
Omada Health
Omada Health
22 Apr 2020
BrainVectis
BrainVectis
Acquired by
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical

Asklepios BioPharmaceutical Acquires BrainVectis

FinSMEs
21 Feb 2019
Immune Design
Immune Design
$300,000,000 From
Merck
Merck

Seattle biotech Immune Design acquired by drug giant Merck for $300M

GeekWire
24 Jul 2018
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc.
Acquired by
Nabriva Therapeutics
Nabriva Therapeutics

Nabriva Bolsters Antibiotics Pipeline with Zavante Acquisition

Xconomy
09 Jan 2017
Lysosomal Therapeutics
Lysosomal Therapeutics
Acquired by
Allergan plc
Allergan plc

Allergan Enters Parkinson's Disease Through Option Arrangement with Lysosomal Therapeutics Inc. (LTI) for its Potential First-In-Class Breakthrough Compounds

prnewswire
11 Nov 2016
Arsia Therapeutics
Arsia Therapeutics
$78,000,000 From
Eagle Pharmaceuticals
Eagle Pharmaceuticals

Eagle Pharmaceuticals to acquire Arsia Therapeutics for $30M

NJBIZ
+2
27 Oct 2016
Motus Therapeutics
Motus Therapeutics
$200,000,000 From
Allergan plc
Allergan plc

Allergan to Acquire Motus Therapeutics Genetic Engineering & Biotechnology News - Biotech from Bench to Business

GEN
02 Sep 2016
DIH
DIH
Acquired by
Hocoma
Hocoma

Together into the future: Hocoma merges with DIH International to provide total solution for modern rehabilitation.

hocoma
+1